ࡱ> CEB  bjbj## 46AAbbbbbvvvv v0   moooooo$jb     bb))) bbm) m)))9nd )Y0):):):b)0  )     )       :          (: FOI Request re Non-Small Cell Lung Cancer (NSCLC) Patients How many of the following patients (excluding clinical trial patients) are currently being managed by your Health Trust: Patient TypeTotal number of patients (treated and not treated) Number currently treated with any active anti-cancer drug treatment (excl. surgery/ radiotherapy only)Number not treatedAll Non-Small Cell Lung Cancer (NSCLC) patients158068Patients with NSCLC Stage IIIB**/IV** (Stage 3b/4)76041 Of the Stage IIIB/IV NSCLC patients, please state the number of patients currently being treated with the following therapies: TherapyNumber of Stage IIIB/IV NSCLC patients currently treated Afatinib (Giotrif)Ceritinib (Zykadia)Crizotinib (Xalkori)Erlotinib (Tarceva)Gefitinib (Iressa)Nintedanib + docetaxelPemetrexed (Alimta) mono or in combination with carboplatin / cisplatinGemcitabine mono or in combination with carboplatin / cisplatinAtezolizumab (Tecentriq)Nivolumab (Opdivo)Pembrolizumab (Keytruda)Paclitaxel mono or in combination with carboplatin / cisplatinDoxetaxel mono or in combination with carboplatin / cisplatinVinorelbine [or other Vinka alkaloid] mono or in combination with carboplatin / Cisplatin If your trust does not treat Stage IIIB/IV NSCLC patients and you refer your patients to another trust, please state to which trust patients are referred. We do not treat patients at this Trust for this condition; they would be referred to The Christie NHS Foundation Trust. ;q r h     0 1 z {   H I  ˹˲˲ܹ˲˲˲˲˲˲˲˲˲˲˲˲˲˲ܤh  h/0h?6CJOJQJ^JaJhDNCJOJQJ^JaJh?6CJOJQJ^JaJ h&ghDN#h&ghDN5CJOJQJ^JaJ h&ghDNCJOJQJ^JaJ h/0hDNCJOJQJ^JaJ#h/0hDN5CJOJQJ^JaJ.;^ q $IfgdX#l gdDNq r H5555$IfgdX#l kd$$Ifl\Zv# t0644 lap(yt&g H5555$IfgdX#l kd$$Ifl\Zv# t0644 lap(yt&g h p HCC..$Ifgd&gl gdDNkd\$$Ifl\Zv# t0644 lap(yt&g xbO$IfgdX#l d$Ifgd&gl kd $$Ifl0# t0644 lapyt&g xbO$IfgdX#l d$Ifgd&gl kd$$Ifl0# t0644 lapyt&g xbO$IfgdX#l d$Ifgd&gl kd>$$Ifl0# t0644 lapyt&g   xbO$IfgdX#l d$Ifgd&gl kd$$Ifl0# t0644 lapyt&g    xbO$IfgdX#l d$Ifgd&gl kdr$$Ifl0# t0644 lapyt&g  / 0 xbO$IfgdX#l d$Ifgd&gl kd $$Ifl0# t0644 lapyt&g0 1 y z xbO$IfgdX#l d$Ifgd&gl kd$$Ifl0# t0644 lapyt&gz { xbO$IfgdX#l d$Ifgd&gl kd@$$Ifl0# t0644 lapyt&g xbO$IfgdX#l d$Ifgd&gl kd$$Ifl0# t0644 lapyt&g xbO$IfgdX#l d$Ifgd&gl kdt$$Ifl0# t0644 lapyt&g   xbO$IfgdX#l d$Ifgd&gl kd$$Ifl0# t0644 lapyt&g  G H xbO$IfgdX#l d$Ifgd&gl kd$$Ifl0# t0644 lapyt&gH I xbO$IfgdX#l d$Ifgd&gl kdB $$Ifl0# t0644 lapyt&g xbO$IfgdX#l d$Ifgd&gl kd $$Ifl0# t0644 lapyt&g xsssqgdDNkdv $$Ifl0# t0644 lapyt&g21h:pDN. A!"#$% $$If!vh#v#v:V l t0655p(yt&g$$If!vh#v#v:V l t0655p(yt&g$$If!vh#v#v:V l t0655p(yt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&g$$If!vh#v#v :V l t0655 pyt&gj 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH J`J DNNormal dCJ_HaJmH sH tH DA D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List t`t DN Table Grid7:V0 dPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 6  q   0 z  H  L# @0(  B S  ? "1;=CIRX#EDN&g ?6@@UnknownG*Ax Times New Roman5Symbol3. *Cx Arial7.@ CalibriACambria Math"qhѻ[ѻ[  !r0KHX  $PDN2!xx Griffiths PamelaGriffiths PamelaOh+'00 px   (Griffiths PamelaNormalGriffiths Pamela2Microsoft Office Word@@nd@nd՜.+,0 hp|  WWL   Title  !"#%&'()*+,-./013456789;<=>?@ADRoot Entry Fw9ndFData 1Table$:WordDocument46SummaryInformation(2DocumentSummaryInformation8:CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q